Viewing on a PDA? Click here to read this email.
Medical Progress Today
mpt home | sign up

Volume 8, Number 15
April 14, 2011


PRINTER FRIENDLY

In the Spotlight

The Real Reason Drug Companies are Failing?

The FDA has gotten tougher, but that's not the only problem.

Josh Bloom, Ph.D., Medical Progress Today, 4-14-11

Trouble in the pharmaceutical industry has become so evident that major news organizations are belatedly taking note of it. This was evidenced by a recent plethora of stories about the slew of looming patent expirations major drug companies are facing. Some important reasons have been examined, but there is much more to the story. As a former pharmaceutical researcher for more than two decades I can fill in a few gaps that are not being discussed.
Continue reading . . .


News

· Medical Device Recalls and the FDA Approval Process, Zuckerman, D. M., Brown, P., Nissen, S. E., Archives of Internal Medicine, 6-14-11
· Patent Reform Gets Key Support in House, Julian Pecquet, The Hill, 6-14-11
· $4.3 Billion Pledged at Vaccine Fund-Raiser, Donald G. McNeil Jr., New York Times, 6-13-2011
· Physicians Leaving Practices for health System Employment, Karen Cheung, FierceHealthcare, 6-13-11

More Headlines >>


Commentary

· Marco Rubio takes on 'Medi-scare' Marc A. Thiessen, Washington Post, 6-13-11
· 'Vouchercare' Is the Right Name for Medicare Laurence Kotlikoff, Bloomberg, 6-15-11
· Built To Fail: Health Insurance Exchanges Under The Affordable Care Act
· Can Exchanges Help Consumers Get Good Value Insurance? Depends On Where You Live Sabrina Corlette, Kaiser Health News, 6-15-11
· The ObamaCare Bad News Continues Karl Rove, Wall Street Journal, 6-16-11
· ObamaCare's Economic Flaws Doug Holtz-Eakin, Investor's Business Daily, 6-8-11

More Commentary >>


Research

· Why States Are So Miffed about Medicaid Economics, Politics, and the "Woodwork Effect", Benjamin D. Sommers et al., New England Journal of Medicine, 6-15-11
· Auditing Access to Specialty Care for Children with Public Insurance, Joanna bisgaier et al., New England Journal of Medicine, 6-16-11
· Moving Beyond Fee-For-Service: The Case for Managed Care in Medicaid, Michael Ramlet and Carey Lafferty, American Action Forum, 6-14-11
· The New Gold Rush: Prospectors are Hoping to Mine Opportunities in the Healthcare Industry, Health Research Institute, PricewatershouseCoopers, 6-14-11
· Active Purchasing for Health Insurance Exchanges: An Analysis of Options, Sabrina Corlette and JoAnn Volk, RWJF, 6-14-11

More Research>>



Medical Progress Today is published by the Center for Medical Progress at the Manhattan Institute for Policy Research.

For more information about Medical Progress Today, please contact the managing editor, Paul Howard, at phoward@manhattan-institute.org, or via telephone at 212.599.7000.

Press inquiries regarding Medical Progress Today can be directed to the Communications Department, at communications@manhattan-institute.org, or via telephone at 212.599.7000.

If you would like to unsubscribe, please reply to us and type "Unsubscribe" in the subject line.

SPOTLIGHT

The Real Reason Drug Companies are Failing?

INNOVATIVE IDEAS:
Podcast Series


In this edition of Innovative Ideas, Paul Howard interviews Scott Harington, a Professor of Health Care Management and Insurance and Risk Management at the University of Pennsylvania's Wharton School of Business on his paper, Incentivizing Comparative Effectiveness Research.

Click here to listen to the podcast

"This type of information, first comparative effectiveness research, but maybe ultimately cost effectiveness research, will provide the basis for determining what is reimbursed under public insurance programs and perhaps ultimately private insurance programs so there's naturally a great degree of angst by some and hope by others that we can use this information to more or less save money without reducing quality by deciding we're only going to pay for what works and we're only going to pay for something that improves health outcomes if according to some criterion the value of the benefit is greater than the cost of the additional treatment."

Center for Medical Progress 
Copyright Manhattan Institute for Policy Research
52 Vanderbilt Avenue
New York, NY 10017
(212) 599-7000
mpt@manhattan-institute.org